Publication | Closed Access

Assessment of a Radiomic Signature Developed in a General NSCLC Cohort for Predicting Overall Survival of ALK-Positive Patients With Different Treatment Types

Radiomic Signature DevelopedOncologyGeneral Nsclc CohortDisease ProgressionPrognosisLung CancerMedicineOverall SurvivalNuclear MedicineRadiology